The Assured Playbook

An Operational Trigger Intelligence playbook
built for Assured.

Ten plays tied to public operational triggers. Three scored deep dives, with role-play diagnostics on every email.

// Last updated: May 8, 2026

The Outbound This Replaces

Every credentialing rep sounds the same. Assured doesn't have to.

Most competitors open with "AI-powered credentialing." This playbook opens with their Series B announcement, their new COO's first 60 days, or their bolt-on acquisition close — then attaches product. Same stack as generic outbound says "we help health systems like yours."

What a generic credentialing rep sends today.

OUTBOUND // GENERIC

Hi [First Name],

I'm reaching out because we work with digital health platforms like yours to streamline credentialing, payer enrollment, and network compliance. Our AI-powered platform helps you onboard providers faster, reduce denials, and stay audit-ready.

I'd love to show you how we've helped similar companies in your space. Do you have 15 minutes this week?

Play 1 signal — Series B/C with state-expansion language.

OUTBOUND // SIGNAL-MATCHED

{{first_name}}, the {{round_size}} announcement said {{N_states}} states by {{target_date}}.

Per-payer enrollment runs 90-120 days at industry baseline and doesn't run in parallel. For digital-health platforms at this stage, that math typically slips the announced timeline by 4-6 months even when the credentialing team is fully staffed.

Pulled together a 1-pager mapping your stated state targets to per-payer enrollment timelines and which payers in {{top_2_states}} are the longest pole. Want me to send it?

Industry baseline of 60-120 days per payer per provider is multi-source confirmed across Aptarro 2026, Atlas Systems' credentialing-turnaround analysis, Verisys, and the MedixRevenue 2026 changes guide. Crunchbase + Fierce Healthcare publish funding announcements with stated expansion language. The signal-matched email above is the post-role-play final draft — see the role-play section below for what got cut.

Activation Summary

Run these three first.

All three target the digital-health and PE-backed multi-site segments where Assured's customer pattern runs deepest. Enterprise IDN (Joint Commission survey window — Play 6) is in the menu but not the top tier — the 12-18-month sales cycle exceeds what early-stage GTM firepower can carry.

#	Play	Persona	Motion	Composite	Status
1	Series B/C with state-expansion math gap	COO / Head of Operations at digital-health Series B/C with explicit multi-state expansion in announcement	Cold	4.80	Ready
2	New COO 90-day stack-review window	COO / VP Operations at digital health, 0-90 days in role, running first stack review	Cold	4.35	Ready
3	PE bolt-on integration math	Platform CFO / COO at PE-backed multi-site (behavioral, dermatology, primary care, ophthalmology)	Cold	4.25	Ready

// Composite scoring (1–5 weighted): Volume 0.20 · Detectability 0.25 · Specificity 0.25 · Timing Precision 0.15 · Actionability 0.15. Full per-dimension breakdowns for all 10 plays in Methodology below.

Pilot order: Play 3 first (Janet was ready to forward to her integration lead in the role-play). Play 1 next, timed inside the 90-day post-announcement window. Play 2 third.

Three Deep Plays

Three plays with full architecture.

Plays 1, 2, and 3 expanded into full architecture: failure mode, trigger conditions, persona reasoning, both message variants, and the PVP spec. The other seven stay in menu format above.

Deep 01_

composite 4.80 · S1

Series B/C with state-expansion math gap

Failure mode: Multi-state expansion gated on credentialing throughput. Capital deployed on a board-committed expansion timeline; per-payer enrollment math will slip that timeline by 4-6 months even when the credentialing team is fully staffed. The COO doesn't know this when the round closes; they will, 60-90 days in.

Trigger · Series B or C funding announcement in the last 90 days where press-release language explicitly references state-by-state expansion (≥3 US state names, or phrases like "national rollout," "expand to N states").

Persona · COO / Head of Operations at the funded org (50-1,000 employees, multi-state expansion mandate fresh from board).

Disqualifiers · Round announced 91+ days ago; provider count >2,000; recent vendor partnership disclosed in same announcement (e.g., "partnered with Medallion").

PVP · One-page per-state-per-payer enrollment-timeline mapping for the prospect's announced state targets, flagging which payers in their top 2 expansion states are the longest pole. Useful even if they never buy — most ops teams haven't built this view themselves.

↓ Artifact — Play 1 (per-state per-payer enrollment timeline one-pager)

Two-column comparison of sequential vs. parallel credentialing across the same illustrative 18-state Series-B expansion plan. California and Texas — repeat longest-pole states for behavioral and virtual-care platforms — get a payer-by-payer breakdown showing why Medi-Cal MCO (California Medicaid Managed Care Organization) and Texas STAR/STAR+PLUS enrollment compounds 30-60 days on top of the commercial baseline. The board-memo timeline projection in each column is the case where the sequencing decision visibly changes the Q4 narrative.

Open one-pager →

Variant A · post-role-play final draft

SUBJECT: {{company_name}} multi-state plan vs. credentialing math

{{first_name}}, the {{round_size}} announcement said {{N_states}} states by {{target_date}}.

Pulled together a 1-pager mapping your stated state targets to per-payer enrollment timelines and which payers in {{top_2_states}} are the longest pole. Want me to send it?

Variant B · {{N_states}}-state plan angle

SUBJECT: the {{N_states}}-state plan from the {{round_size}} round

{{first_name}}, {{company_name}} at {{provider_count}} providers across {{state_count}} states with {{N_states}} more on the {{round_size}} announcement.

Industry-baseline 90-120 day per-payer enrollment turns the announced state map into an 18-month sequence even when the team is fully staffed. The pattern peers usually surface 90 days post-round.

Mapped how peer Series-B telebehavioral COOs re-sequenced and where the leverage points were. Want me to send it over?

Key sources

→ Crunchbase — funding rounds + announcement text
→ Fierce Healthcare Fundraising Tracker
→ LinkedIn — current ops leadership (COO / Head of Provider Network)

Deep 02_

composite 4.35 · S2

New COO 90-day stack-review window

Failure mode: Revenue trapped behind credentialing delay + expansion gated. A new COO at a Series A-C digital-health platform has a one-time political mandate to rebuild the operations stack. The 0-90 day honeymoon window is when stack decisions get made; beyond that, the new exec settles into existing systems and the friction-cost of change rises.

Trigger · LinkedIn job-change event for COO / VP Operations / Head of Operations / Head of Provider Network at digital-health (50-1,000 employees) where the role started in the last 90 days.

Persona · Newly-hired COO / VP Operations at a Series A-C digital-health platform, 0-90 days in role.

Disqualifiers · Prior role at credentialing competitor (Medallion / Symplr / Verifiable / CertifyOS); <50 employees; >120 days in role.

PVP · One-page "credentialing leverage read" for the prospect's company stage — current ops-stack benchmarks (FTE-to-provider ratios, FPAR (First-Pass Approval Rate) ranges, per-payer enrollment timelines) at peer digital-health platforms in their state count + provider count band. Useful as planning artifact whether or not they buy.

Variant A · post-role-play final draft

SUBJECT: {{first_name}}, 60 days in, credentialing on the list?

{{first_name}}, most ops leaders stepping into multi-state digital-health roles tell me the same thing. Credentialing throughput is the ops-stack item the previous team lived with but the new one can't.

Industry baseline is 60-120 days per provider per payer. {{company_name}} at {{provider_count}} providers across {{state_count}} states means the math compounds fast. Your team is doing real work, the question is throughput at full expansion scale, not effort.

Have a quick read on where digital-health platforms at your stage typically have the most credentialing leverage. Should this go to you or {{cred_lead}}?

Variant B · 90-day stack-review angle

SUBJECT: 90-day stack review, credentialing leverage

{{first_name}}, saw you started at {{company_name}} {{weeks_in_role}} weeks ago. {{company_name}} at {{provider_count}} providers across {{state_count}} states off the {{round_size}} round, the math compounds fast.

Ops leaders running 90-day stack reviews at digital-health platforms typically find credentialing-throughput is the highest-leverage replacement. Incumbents ship at industry baseline of 60-120 days per provider per payer; AI-native vendors claim 2 days.

Mapped where peers found the leverage in their first quarter. Should this go to you or {{cred_lead}}?

Key sources

→ UserGems — LinkedIn job-change tracking
→ Champify — alternative
→ LinkedIn Sales Navigator — manual saved-search fallback

Deep 03_

composite 4.25 · S3

PE bolt-on integration math

Failure mode: Operational scaling wall + M&A integration credentialing chaos. PE add-on transactions in healthcare are up 19% YoY. Every bolt-on inherits the acquired entity's full credentialing + payer-contract debt — a 4-6 month integration handoff most platform integration teams don't fully cost into the deal model. The 30-60 day post-close window is where the math becomes visible.

Trigger · PE-platform bolt-on acquisition close announced in the last 60 days in behavioral health, dermatology, ophthalmology, primary care, or dental specialties.

Persona · Platform CFO or COO at the PE-backed multi-site (often a former operator hired by the sponsor for integration ops; reports to PE deal team + platform CEO).

Disqualifiers · Acquisition >60 days post-close; platform <50 total providers post-close; acquired entity is fully out-of-network.

Selection note · Selected over Play 5 (vendor detractor) at lower composite score because (a) the PE-platform CFO buyer is the highest-friction-to-reach but highest-ACV persona in the menu, (b) Janet Rodríguez's role-play surfaced the strongest "ready to send today" signal of any of the three personas, (c) Assured's Platinum Dermatology Partners reference logo lands directly here.

PVP · One-page integration-credentialing handoff timeline for the prospect's specialty + state mix — comparing the typical 4-6 month industry-baseline handoff vs. the 60-day acceleration path peer platforms have implemented. Useful even if they never buy — most platform CFOs run the post-close ops review with limited cross-platform benchmark data.

Variant A · post-role-play final draft

SUBJECT: {{acquired_entity}} integration math

{{first_name}}, saw the {{acquired_entity}} close.

Most credentialing handoffs at PE-platform bolt-ons run 4-6 months even at well-run platforms. Providers re-credentialing under the platform name, payer-contract consolidation, primary-source verification, panel-loading. That's a quarter+ of billing capacity off the table per acquisition.

Have a one-pager mapping the 60-day acceleration path platforms in {{specialty}} have used post-bolt-on. Should this go to you or {{integration_lead}}?

Variant B · sponsor-review angle (Janet: "send B")

SUBJECT: {{platform_name}} integration AR, sponsor-review framing

{{first_name}}, most PE-backed {{specialty}} platforms surface the same Q+1 (first quarterly review post-close) pattern post-bolt-on.

Credentialing-driven AR aging shows up in the sponsor's first quarterly review and pulls the billing-capacity ramp 4-6 months behind the deal model, even at well-run platforms. Per-acquisition, that's a quarter+ of billing capacity on the table.

Have a one-pager on how peer platforms in {{specialty}} re-sequenced the integration handoff to compress that window to 60 days. Should this go to you or {{integration_lead}}?

Key sources

→ Private Equity Stakeholder Project (PESP) — monthly PE healthcare M&A reports
→ Behavioral Health Business
→ PitchBook M&A feed (paid)

Recipient Role-Play

Three subagents read the cold emails in character. This is what they said.

Each subagent was given a concrete persona — Series-B telebehavioral COO, newly-hired virtual-care COO, PE-backed dermatology platform CFO — and asked to react honestly to the pre-revision versions of Variant A and Variant B. Their reactions drove specific edits. The post-revision drafts in the deep-play section above reflect every catch logged below.

// This is the part of the workflow that doesn't compress to a one-shot prompt. The recipient-side reactions — what trips, what reads as automation, what register breaks the spell — are where the message actually gets debugged.

Recipient · Play 1

Sarah Chen — digital-health COO, Series B closed 7 weeks ago

39, COO at Mindlight Therapy · ex-Talkspace VP Ops · 92 providers across 7 states · post-board-call, Q1 expansion-pace miss

+ Read transcript − Collapse

Killer catch

"Out-of-the-box is a SaaS phrase. A COO version would be cleaner."

Edits this drove

Dropped "out of the box." Added one sentence acknowledging the existing credentialing team is doing real work. Em-dash hygiene tightened.

Scene

Friday morning, May 8, 2026. Roughly 7 weeks post-Series-B announcement, 3 days after the board call. Sarah is at her standing desk at 7:50am, between her morning ops standup and a 9am with Karen (her credentialing manager) to review the May enrollment pipeline. Coffee on the third refill. Going through the inbox triage before standup. The board chair asked her on Tuesday when state 12 would be live; she didn't have a date.

Pre-revision Variant A

Subject: Mindlight Therapy multi-state plan vs. credentialing mathHi Sarah, The $45M announcement said 18 states by Q4 2026. Per-payer enrollment runs 90-120 days at industry baseline and doesn't run in parallel out of the box — for digital-health platforms at this stage, that math typically backs the expansion timeline up by 4-6 months. Pulled together a 1-pager mapping your stated state targets to per-payer enrollment timelines and which payers in California and Texas are the longest pole. Want me to send it?

Pre-revision Variant B

Subject: How peer Series B platforms sequenced their 18-state buildoutWatched a peer Series B telebehavioral org (similar provider count, 16-state target) work through the credentialing-throughput math 90 days post-round. The pattern: industry-baseline 90-120 day per-payer enrollment turns the announced state map into an 18-month sequence even when the team is fully staffed. Mapped how they re-sequenced and where the leverage points were. Want me to send it over?

Sarah's reaction · 7:50am, between standup and the 9am with Karen

5-second reaction. Variant A subject — "Mindlight Therapy multi-state plan vs. credentialing math." Direct. Names the company without congratulating me on the round. Not flattery, not vague — and the word "math" in a subject is a small pattern interrupt. I'd open it. Variant B subject — "How peer Series B platforms sequenced their 18-state buildout." Hmm. Reads like a headline I'd see in Becker's. The "peer Series B" framing is a weaker hook than naming Mindlight outright; if you don't know which company you're talking to in the subject, why am I going to keep reading?

What lands. Variant A: "doesn't run in parallel out of the box." That's the real line. That's the line I've been internally saying to myself since Tuesday. Industry-baseline 90-120 days per-payer is roughly right for the commercial side. The 4-6 month expansion-timeline-slippage framing matches what I'd write on a board memo if I were being honest about the Q4 plan. Then naming California and Texas as the longest pole: California Medi-Cal MCO enrollment is hell, every behavioral-health COO who's tried it has war stories. Naming those two specifically — not just "your top expansion states" — earns trust that this isn't a sequence-tool guess.

AI-SDR pattern-match. Variant A doesn't pattern-match to AI-SDR — there's no scraped-stat opener, no congrats-on-the-round, no obvious template hook. The "$45M announcement said 18 states by Q4 2026" is the kind of fact that would be hard to fake, but a sequence tool COULD scrape it from Crunchbase. The save: it's the only Crunchbase fact in the email and it's used to set up the actual insight. That's craft, not template. Variant B has an AI-SDR-ish quality from the "Watched a peer Series B telebehavioral org" framing. If you can't name the peer, the social proof is doing work it hasn't earned.

Off-register. Variant A: "the math typically backs the expansion timeline up" — "backs up" is a slightly weird phrasing. Most COOs would say "slips" or "pushes the timeline out." Both emails: "doesn't run in parallel out of the box" — software-y. Out-of-the-box is a SaaS phrase. A COO version would be "doesn't run in parallel" or "doesn't run in parallel without a separate sequencing layer."

Would I reply? Variant A — yes, I'd reply with "send it." Two minutes of effort, three named data points (the round size, the state target, my two longest-pole states), and a useful artifact on offer. The Tuesday call primes me to want the data. Variant B — probably not. The unnamed peer plus the lack of a Mindlight-specific data point makes it feel like a piece of content I could find on a blog.

Cut / Add. Cut from Variant B: "Watched a peer Series B telebehavioral org (similar provider count, 16-state target)" — either name a peer or drop the social proof. Add to Variant B: A Mindlight-specific anchor in the first line. Even one fact about Mindlight earns the rest of the message. Optional add to both: One sentence acknowledging that Karen / the existing credentialing team is doing real work — pitching directly at "your team is the bottleneck" reads as criticism. The COO will forward this to Karen if it lands; making Karen the villain is a fast way to get the email killed.

Recipient · Play 2

Marcus Patel — new COO at Series A virtual-care, 52 days in role

44, COO at Vita Care · ex-One Medical VP Ops + ex-Forward Director of Ops · 145 providers across 8 states · 60 days into a 90-day operations review

+ Read transcript − Collapse

Killer catch

"The 10-20x speed and 3-5x first-pass approval multiples invite skepticism the rest of the email then has to overcome."

Edits this drove

Multiples replaced with concrete numbers (60-120 days vs. 2 days). Vita Care-specific anchor added in para 2. Routing question to Diane added.

Scene

Friday afternoon, May 8, 2026. 4:15pm. Marcus is at his home office in Brooklyn between a 4pm payer-relations sync and a 5pm 1:1 with the CFO. He's been writing notes for the systems-replacement memo on a yellow legal pad next to his laptop. Wednesday's 1:1 with the credentialing manager (Diane) ended with her saying "I think we need a system change but I don't have the bandwidth to evaluate one." Marcus has been carrying that line in his head for two days.

Pre-revision Variant A

Subject: Marcus, 30 days in — credentialing on the list?Hi Marcus, Most ops leaders stepping into multi-state digital-health roles tell me the same thing — credentialing throughput is the ops-stack item the previous team lived with but the new one can't. Industry baseline is 60-120 days per provider per payer. Vita Care at 145 providers across 8 states means the math compounds fast. Have a quick read on where digital-health platforms at your stage typically have the most credentialing leverage. Want me to send it?

Pre-revision Variant B

Subject: 90-day stack review — credentialing leverage mapHi Marcus, Saw you started at Vita Care 7 weeks ago. Ops leaders running 90-day stack reviews at digital-health platforms typically find the credentialing-throughput line item is the highest-leverage replacement — incumbents ship 60-120 days per provider per payer; the gap to AI-native is 10-20x on speed and 3-5x on first-pass approval. Mapped where peers found the leverage in their first quarter. Should this go to you or Diane?

Marcus's reaction · 4:15pm, between the 4 and the 5

5-second reaction. Variant A subject — "Marcus, 30 days in — credentialing on the list?" — that's a 4-second pause for me. The "30 days in" is wrong (I'm at 52, but the gist is right) and the "on the list?" framing reads as someone who actually knows what a 90-day review looks like. I'd open it. Variant B subject — "90-day stack review — credentialing leverage map." Direct, but more like a headline than a question. Less hook. I'd open it second.

What lands. Variant A: "credentialing throughput is the ops-stack item the previous team lived with but the new one can't." That's the line. That's exactly the framing I had on Wednesday with Diane. It's almost word-for-word what I wrote in my legal pad. So either this person reads exec ops-leaders' minds or they've worked with enough new COOs at this stage to have heard the same sentence a hundred times. Either way, lands. The "145 providers across 8 states means the math compounds fast" — yes, true, and the specific provider count + state count tells me they pulled real numbers, not a template. Variant B: "the gap to AI-native is 10-20x on speed and 3-5x on first-pass approval." First reaction: skeptical. 10-20x on speed is vendor-defensible. But "3-5x on first-pass approval" — that's harder to defend. To get to 3-5x you have to redefine the metric (denial rate? then yes, 5x reduction is plausible). The ambiguity hurts.

AI-SDR pattern-match. Variant A doesn't pattern-match. The "ops-stack item the previous team lived with but the new one can't" is too specific to be a sequence-tool template; it's a real observation. The "30 days in" is slightly off (I'm at 52) but the framing isn't wrong, and a real human writing 100 of these a quarter would round. Variant B has more pattern-match risk. The "10-20x / 3-5x" multiple-anchor pair is the kind of thing AI-SDR sequence tools generate. If this is a real human, they should defend the 3-5x first-pass approval claim with a footnote or a specific source.

Off-register. Variant A: "credentialing leverage" in the closing — slightly buzzy. A COO version would be "where the throughput gains actually come from" or "where the time savings actually live." Leverage is the soft Stanford-MBA word. Variant B: "AI-native" twice. AI-native is having a moment in 2026 — every vendor uses it. It's not wrong, but it's noise. I'd respect the email more if the framing were "purpose-built for parallel multi-payer enrollment" or something concrete.

Would I reply? Variant A — yes. The "credentialing on the list?" subject + "previous team lived with but new one can't" line + the specific Vita Care numbers makes me trust this person enough to spend two minutes asking what's in the read. I'd reply with "yes, send it" and probably bcc Diane. Variant B — maybe. The "Diane" routing question helps. But the 10-20x / 3-5x claims need defense before I'd internalize them.

Cut / Add. Cut from Variant A: Nothing major. The "30 days in" is slightly off — tighten to "60 days in" or "your first quarter." Cut from Variant B: The "10-20x on speed and 3-5x on first-pass approval" multiples. Either back them up with a citation or replace with concrete numbers ("incumbents ship 60-120 days; AI-native vendors claim 2 days"). Add to Variant B: A Vita Care-specific anchor in paragraph 2 (provider count + state count + Series A round size). Variant A has it, Variant B doesn't. Add to both: Diane should appear in BOTH variants' routing question. The "Should this go to you or Diane?" pattern is the strongest acceptable CTA for this persona.

Recipient · Play 3

Janet Rodríguez — CFO at PE-backed dermatology platform, 39 days post-bolt-on

51, CFO at Atlas Skin Partners · ex-Allergan VP Finance + ex-Goldman healthcare IB · 31 practices, 195 providers, 6 states · Audax quarterly review in 4 weeks · operating partner asked Tuesday why Coastal was at week 5 with zero billable providers

+ Read transcript − Collapse

Killer catch

"Compress is vendor-pitchy. CFOs say cut or shorten."

Edits this drove

"Privileging review" replaced with payer-contract consolidation specifics. CTA upgraded to "Should this go to you or Tom?" "Even at well-run platforms" softener added.

Scene

Friday afternoon, May 8, 2026. 3:30pm. Janet is at her midtown office between a 3pm with the controller and a 4pm sponsor-prep meeting. Inbox open on her second monitor. The Audax deck is on her main monitor — she's been editing the standardization slide for 25 minutes and getting nowhere. The Coastal Dermatology integration is at week 5 with 0 of 22 providers re-credentialed under the Atlas TIN. Tom (Director of Provider Operations) keeps telling her "we're working through Symplr; the bottleneck isn't us, it's their queue."

Pre-revision Variant A

Subject: Coastal Dermatology Group integration mathHi Janet, Saw the Coastal Dermatology Group close. Most credentialing handoffs at PE-platform bolt-ons run 4-6 months — providers re-credentialing under the platform name, payer-contract consolidation, privileging review. That's a quarter+ of billing capacity off the table per acquisition. Have a one-pager mapping the 60-day acceleration path platforms in dermatology have used post-bolt-on. Should this go to you or Tom?

Pre-revision Variant B

Subject: Atlas Skin Partners integration AR — sponsor-review framingHi Janet, Most PE-backed dermatology platforms surface the same Q+1 pattern post-bolt-on — credentialing-driven AR aging shows up in the sponsor's first quarterly review and pulls the billing-capacity ramp 4-6 months behind the deal model. Have a one-pager on how peer platforms re-sequenced the integration handoff to compress that handoff window to 60 days. Want me to send it?

Janet's reaction · 3:30pm, Audax deck still open on the main monitor

5-second reaction. Variant A subject — "Coastal Dermatology Group integration math." Direct. Names the specific deal. Doesn't congratulate, doesn't fluff. The word "math" earns the second look. Open. Variant B subject — "Atlas Skin Partners integration AR — sponsor-review framing." Stronger than Variant A actually. "Sponsor-review framing" tells me whoever sent this knows that I have an Audax deck on my screen this week. That's a real signal. Open immediately.

What lands. Variant A: the Coastal callout in the first line earns trust. The "4-6 months" range matches my experience and the AR aging on Coastal specifically (week 5, zero billable). "Quarter+ of billing capacity off the table per acquisition" — that's CFO language, that's how I'd write it on the deck. The routing question naming Tom is the kill move. Tom is exactly who would receive this if it landed at me — same as if I forwarded it. Whoever wrote this did the LinkedIn org-walk and figured out the roles. That's craft. Variant B: "credentialing-driven AR aging shows up in the sponsor's first quarterly review and pulls the billing-capacity ramp 4-6 months behind the deal model." That's the line. That is literally the exact problem on my deck right now. The sender's framing is identical to how the Audax operating partner framed it on Tuesday. They're meeting me where I am. The closing CTA in Variant B is weaker than Variant A's: "Want me to send it?" doesn't route. Variant A's "Should this go to you or Tom?" is better.

AI-SDR pattern-match. Variant A is too specific to be templated. "Saw the Coastal Dermatology Group close" plus the routing-to-Tom move is hand-crafted. Variant B is more general — "PE-backed dermatology platforms" instead of "Atlas." But the sponsor-review framing is the strongest hook in the email and not the kind of language a generic sequence tool would generate. Mixed read.

Off-register. Variant A: "Privileging review" — okay, but most CFOs will think of payer credentialing first; privileging is the clinical side. Could clarify. Variant B: "Most PE-backed dermatology platforms surface the same Q+1 pattern" — "Q+1" is a CFO/PE-deal-team idiom. Lands well. Both: "compress that handoff window to 60 days" — vendor-pitchy. CFOs don't say "compress" much; we say "cut" or "shorten."

Would I reply? Variant A — yes. The Coastal callout + the routing-to-Tom + the dermatology specificity adds up to a 30-second reply. I'd write back "send it to me, copy Tom" and forward to my deck-prep folder. Possible the 1-pager actually informs the standardization slide. Variant B — yes, but I'd reply with a friction-y question: "what's the data behind the 60-day handoff claim?" before reading further. The sponsor-review framing is too good to ignore but the "60 days" claim has to be defensible.

Cut / Add. Cut from Variant A: "Privileging review" — replace with "payer-contract consolidation, primary-source verification, panel-loading." Cut from Variant B: "Want me to send it?" — replace with "Should this go to you or Tom?" to match Variant A's routing strength. Add to both: A specific Audax-portfolio-benchmark callout if the sender has one. As written, the offer is "platforms in dermatology" — generic. If the sender can say "platforms in your sponsor's portfolio" (when true), the credibility jumps another notch. Add to Variant A: One sentence acknowledging that the 4-6 month timeline is the industry norm even at well-run platforms. Without it, the email reads as accusatory; with it, it reads as commiserating with a known industry pattern.

Role-Play Revision Log

What got cut, and the catch that drove it.

Edits derived from the Sarah / Marcus / Janet transcripts. Every change in the post-revision drafts traces to a specific recipient catch.

Play	Edit	Recipient catch driving it
1 Variant B	Dropped "Watched a peer Series B telebehavioral org (similar provider count, 16-state target)" framing. Replaced with a Mindlight-specific anchor in line 1.	Sarah: "If you can't name the peer, the social proof is doing work it hasn't earned."
1 (both)	Added one sentence acknowledging the existing credentialing team is doing real work — "Your team is doing real work, the question is throughput at full expansion scale, not effort."	Sarah: "The COO will forward this to Karen if it lands; making Karen the villain is a fast way to get the email killed."
1 (both)	Replaced "doesn't run in parallel out of the box" with "doesn't run in parallel."	Sarah: "Out-of-the-box is a SaaS phrase. A COO version would be cleaner."
2 Variant A	Changed "30 days in" to "60 days in" — match the actual signal-trigger window.	Marcus: "30 days in is wrong but the gist is right. Tighten it."
2 Variant B	Dropped the "10-20x on speed and 3-5x on first-pass approval" multiples. Replaced with concrete numbers ("incumbents ship at industry baseline of 60-120 days per provider per payer; AI-native vendors claim 2 days").	Marcus: "The multiples invite skepticism that the rest of the email then has to overcome."
2 Variant B	Added a Vita Care-specific anchor in paragraph 2 (provider count + state count + Series A round size).	Marcus: "As written, Variant B could be sent to any Series-B telebehavioral COO; that's the AI-SDR tell. Even one Vita Care-specific fact earns the rest."
2 (both)	Named the credentialing lead ({{cred_lead}}) in the routing question of both variants. Variant A previously didn't.	Marcus: "The 'Should this go to you or Diane?' pattern is the strongest acceptable CTA for this persona."
3 Variant A	Replaced "privileging review" with "payer-contract consolidation, primary-source verification, panel-loading."	Janet: "Privileging review — most CFOs think of payer credentialing first; privileging is the clinical side. Could clarify."
3 Variant B	Changed CTA from "Want me to send it?" to "Should this go to you or {{integration_lead}}?" — match Variant A's routing strength.	Janet: "Variant A's 'Should this go to you or Tom?' is better. Variant B has the stronger hook but the weaker close."
3 Variant A	Added one sentence acknowledging 4-6 months is the industry norm "even at well-run platforms." Variant B got the same treatment.	Janet: "As written, the 4-6 month framing reads as 'you're slow.' Adding 'even well-run platforms' makes it 'we're solving an industry problem together.'"
All 3	Em-dash hygiene: replaced `{{first_name}} — saw...` patterns with `{{first_name}}, saw...` (comma) before loading into the sequencer.	Pattern-match flagged across all three transcripts; em-dash usage is one of the AI-SDR tells specialists use when triaging inbound.

General observation

All three recipients downgraded the variant that pattern-matched to AI-SDR conventions — scraped-stat opens, em-dashes mid-sentence, "out-of-the-box" SaaS language, unnamed peer social proof. None of the three would explicitly write back "this is AI-generated, ignore." But all three quietly demoted the AI-SDR-flavored variant's reply likelihood. The silent-killer pattern is the most important thing to debug pre-send.

Signal Stacks

Three pain-point clusters.

Each cluster pairs a Current State (the painful present) with a Desired Future (what they want to become), plus a stack of situational, execution, and pain signals that confirm the operator is in that pattern. Stacks come from the intelligence brief.

PP1 · Revenue trapped behind credentialing delay

Current state

Newly-hired providers sit in 60-120 day credentialing limbo. Each one represents $50K-$1M+ in delayed billing. Payers cross-check CAQH/state boards/Medicare aggressively in 2026 — single mismatched datapoints cause weeks of accumulating denials before root-cause is identified. The CFO is asking why bad-debt jumped Q-over-Q.

Desired future

Provider hire → credentialed in 2 business days → billable within first month. AR cleared. Revenue ramp matches headcount ramp.

Type	What to look for	Why it matters
Situational	Series B/C funding announcement with state-expansion language	Capital deployed for expansion forces credentialing into critical path
Execution	Aggressive credentialing-specialist / MSS (Medical Staff Services) hiring vs. provider headcount	Throwing people at the problem = pre-automation buying window
Pain	Public complaint posts about Medallion / Symplr / Verifiable	Active dissatisfaction; switching window open

PP2 · Multi-state expansion gated on credentialing throughput

Current state

Series B raised on a "20 states by year-end" thesis. PSYPACT + IMLC give compact-licensure relief but DO NOT speed payer enrollment. Marketing announces "we now serve [State X]" — operations realizes 60 days later that no payer in that state has the providers credentialed yet. Expansion thesis slipping by 6-9 months.

Desired future

Compact-state activation triggers a parallel multi-payer-enrollment pipeline that closes within the same quarter as the licensure step.

Type	What to look for	Why it matters
Situational	Series B/C funding + expansion language	Stated state-target creates the timeline
Execution	PSYPACT / Counseling Compact / IMLC state-membership addition	False-comfort wedge — compact relief on licensure ≠ payer-enrollment relief
Pain	New COO / VP Ops / Head of Provider Network hire	New exec inherits the unmet expansion timeline

PP3 + PP4 · Joint Commission cliff + PE roll-up integration chaos

Current state

JC SAFER matrix (effective Jan 1, 2026) prioritizes deficiencies from past surveys. Version drift on credentialing files is the most common root cause of findings. NCQA tightened recredentialing timeframes. Meanwhile a PE platform just absorbed 2-4 bolt-on practices; integration team has 60 days to consolidate hundreds of providers onto the platform's credentialing system.

Desired future

Audit-ready credentialing infrastructure with automated audit trails + monthly monitoring. Bolt-on integrations consolidate within 30-60 days without breaking process.

Type	What to look for	Why it matters
Situational	Joint Commission survey window approaching (12-18 months out) OR PE platform bolt-on close in last 60 days	Survey-prep budget cycle / integration window open
Execution	Aggressive credentialing-specialist hiring at the platform/health-system	Throughput pressure surfaces in HR before it surfaces in vendor RFPs
Pain	OIG LEIE exclusion at peer org OR public-co credentialing receivable disclosure	Compliance officer / CFO pressure spike

Methodology

Composite scoring rubric.

Every signal scored 1–5 across five weighted dimensions. The activation order falls out of the math.

+ Scoring methodology + per-play scores (all 10 plays)

Volume · 0.20

Qualifying events / quarter.

Detectability · 0.25

Accessible via APIs / RSS / scrape.

Specificity · 0.25

Forced event vs. weak indicator.

Timing · 0.15

Action window clarity.

Actionability · 0.15

Can the right contact be reached.

Play	Vol	Det	Spec	Time	Act	Composite
Play 1 · Series B/C state expansion	4	5	5	5	5	4.80
Play 2 · New COO 90-day	3	4	5	5	5	4.35
Play 3 · PE bolt-on integration	4	4	5	4	4	4.25
Play 8 · Health-system M&A	4	5	4	4	4	4.25
Play 7 · Compact false-comfort	3	3	5	5	5	4.10
Play 5 · Vendor detractor	2	5	4	4	4	3.85
Play 6 · JC survey window	4	3	5	3	4	3.85
Play 4 · Cred-team hiring ratio	5	4	3	3	4	3.80
Play 9 · OIG LEIE peer event	4	5	3	3	3	3.70
Play 10 · Public-co AR disclosure	1	4	5	4	4	3.65

// Source: gtm-alpha/runs/withassured.com/brief.md. Composite = (V × 0.20) + (D × 0.25) + (S × 0.25) + (T × 0.15) + (A × 0.15).

More Plays

Seven more plays. Ranked by composite.

Plays 4–10. Top runner-up (Play 8 — Health-system M&A) ties with Play 3 at 4.25. Lowest-volume play (Play 10) earns its keep on highest-ACV CFO outreach.

+ What “Cat B” / “Cat A/B” means in the cards below

Cat A — prospect-specific telemetry (their data, not ours). Cat B — single public fact about the prospect (funding round, job change, survey window). Cat C — aggregated benchmark from the vendor’s customer base.

Seven of the ten plays in this playbook are Cat B. Two are Cat B/C hybrid (public fact + multi-system framing). Play 4 is Cat A/B hybrid — the only one that depends on Assured packaging its own benchmark data. Cat A primary is empty by design until that packaging exists.

+ Show 7 more plays (composite 3.65–4.25)

Play 8 · Cat B/C · Public

composite 4.25

Health-system / multi-site M&A integration

Health-system or strategic multi-site acquisition announcements. Acquirer inherits all of acquired entity's providers + payer enrollments + privileging files; 60–180 day integration window.

+ Send-ready email

Subject: {{target_org}} integration credentialing

{{first_name}}, saw the {{target_org}} close.

Most credentialing handoffs at IDN-level integrations run 4-6 months. Providers re-credentialing under the acquirer's name, privileging-committee review, payer-contract consolidation. The 60-day post-close window is where the math gets locked in.

Have a 1-pager mapping how peer health systems compressed that handoff window. Should this go to you or {{integration_lead}}?

Play 7 · Cat B · Public

composite 4.10

Behavioral-health licensure-compact false-comfort wedge

When PSYPACT, Counseling Compact, or Social Work Compact adds a state, behavioral-health platforms claim coverage 30 days before payer enrollment catches up. False-comfort window.

+ Send-ready email

Subject: {{state_name}} compact licensure vs. payer enrollment

{{first_name}}, saw {{company_name}}'s compact-licensure coverage of {{state_name}}.

Compact relief solves licensure but doesn't speed payer enrollment. Every commercial payer in {{state_name}} still runs the 90-120 day per-provider enrollment cycle.

Have a 1-pager mapping how peer behavioral-health platforms work the parallel payer-enrollment pipeline post-compact-activation. Want me to send it?

Play 5 · Cat B · Public

composite 3.85

Medallion / Symplr / Verifiable detractor signal

Public complaint posts about incumbent credentialing vendors on Reddit, Capterra (1–3 stars), G2 detractor reviews, MGMA Forum. Active dissatisfaction = switching window open.

+ Send-ready email

Subject: Saw your {{vendor_name}} note

{{first_name}}, read your post on {{platform}} about {{specific_issue}}.

We hear that exact pattern from teams switching off {{vendor_name}}, particularly at multi-state digital-health and PE-backed multi-site groups.

Have a 1-page comparison of how teams in your segment are reframing that switching decision. Want me to send it?

Play 6 · Cat B · Public

composite 3.85

Joint Commission survey window 12–18 months out

Health systems with last JC survey 18–30 months ago. SAFER matrix (Jan 2026) prioritizes prior-survey findings; orgs with past competency-assessment or peer-review issues are now exposed in their priority score.

+ Send-ready email

Subject: {{hospital_name}} survey window, SAFER matrix prep

{{first_name}}, {{hospital_name}}'s last Joint Commission survey decision was {{last_survey_date}}.

The new SAFER matrix prioritizes past-finding categories at the next survey, and credentialing-file version drift is the most-cited tracer-finding root cause.

Have a 1-pager mapping how peer IDNs are prepping credentialing infrastructure for the new standards. Want me to send it?

Play 4 · Cat A/B · Public + Internal

composite 3.80

Credentialing-team hiring vs. provider-count ratio

2+ open credentialing-coordinator / MSS / payer-enrollment postings in 90 days. Hiring is the visible response to volume; the FTE-to-provider math is the wedge.

+ Send-ready email

Subject: {{company_name}} credentialing throughput math

{{first_name}}, saw {{posting_count}} open credentialing roles at {{company_name}} in the last 90 days.

The industry rule is one specialist per 150-200 providers single-state, dropping to one per 50-100 multi-state. At {{provider_count}} providers across {{state_count}} states, you'd need {{calculated_FTE_count}} FTEs to hold the line.

Have benchmark data on where platforms at your size hit the inflection where automation overtakes hiring. Want me to send it?

Play 9 · Cat B · Public

composite 3.70

OIG LEIE peer-segment exclusion event

OIG monthly LEIE updates show 7 exclusions per business day. A peer-segment exclusion = "could this happen here" trigger that opens compliance-officer audit cycles.

+ Send-ready email

Subject: {{peer_segment}} exclusion + monitoring cadence

{{first_name}}, OIG just excluded {{peer_provider_name}} ({{state}}, {{specialty}}) in the {{month}} update.

Most compliance teams in {{segment}} are auditing their monitoring cadence right now. Annual screening leaves you exposed up to 364 days; monthly leaves up to 28.

Have a 1-pager on the continuous-monitoring frameworks peer orgs in {{segment}} are moving to. Want me to send it?

Play 10 · Cat B · Public

composite 3.65

Public-co credentialing receivable disclosure

Credentialing-related receivable holdback or RCM-related guidance miss in 10-K, 10-Q, 8-K filings. Board-disclosed = admission. CFO under pressure to drive system review.

+ Send-ready email

Subject: {{company_name}} {{quarter}} guidance, credentialing AR

{{first_name}}, saw the {{filing_type}} note on credentialing-driven AR.

Industry surveys show 1 in 5 hospitals lose >$1M/yr to enrollment delays, and the 2026 commercial denial-rate climb to 15-17% is making the back-half worse.

Have a 1-pager on how peer public-co RCM teams are reframing credentialing infrastructure as an AR-recovery lever. Should this go to you or {{RCM_lead}}?

Claim Sources

Every number, sourced.

Every specific number, percentage, or capability assertion that appears in a deep-play message. No claim enters a message without a named public source, a vendor-published source, or a plain-language qualifier.

+ Show full claim-source table (16 entries) & treatment notes

Claim	Source	Tier	Treatment
"60-120 days at industry baseline"	Aptarro 2026 + Atlas Systems credentialing-turnaround + Verisys + MedixRevenue 2026	Multi-source public	Use directly. Frame as "industry baseline."
"$50K+ unrealized revenue per 90-day delay per provider"	HitConsultant April 2026	Named public source	Use with attribution.
"1 in 5 hospitals lose >$1M/yr from credentialing delays"	Industry surveys cited in Legacy Consulting Services Feb 2026	Named public source	Use directly with "industry surveys show" framing.
"Commercial + MA denial rates 15-17% in 2026"	Aptarro 2026; MGMA stat polls	Named public source	Use with attribution.
"OIG LEIE adds 7 exclusions per business day"	oig.hhs.gov/exclusions; ExclusionScreening 2026	Named public source	Use directly.
"Joint Commission Jan 2026 SAFER matrix"	jointcommission.org accreditation 360 FAQ; HealthStream 2026	Named public source	Use directly.
"PSYPACT now 43 states; Montana joined Oct 2025"	psypact.org member-state list	Named public registry	Use directly.
"PE add-on healthcare transactions up 19%"	PESP 2026 reports	Named NGO research	Use with attribution.
"1 specialist per 150-200 providers single-state; 1 per 50-100 multi-state"	Industry rule referenced in Atlas Systems credentialing-turnaround analysis + cred-services articles	Industry rule of thumb	Use with "industry rule of thumb" framing.
"FPAR average 83%; top performers 95%+"	HitConsultant April 2026 first-pass-approval analysis	Named public source	Use with attribution.
"NCQA-Certified Credentials Verification Organization"	withassured.com; competitor-comparison pages	Vendor-published cert	Use directly.
"2 business days credentialing turnaround"	withassured.com homepage + funding announcement	Vendor-reported	Use with "vendor-reported" qualifier or omit and use industry baseline framing.
"Customer credentialed providers in <30 days, expanded to 40 states"	withassured.com funding announcement	Vendor customer report	Cite as "Assured customer reports."
"Beacon Behavioral Partners acquired Carolina Psychiatry, Feb 2026"	PESP February 2026 PE Healthcare Acquisitions report	Named NGO research	Use as illustrative example.
"Medallion raised $43M + launched CredAlliance, Aug 2025"	PRNewswire Sep 2025; Medallion press release	Named public source	Use sparingly (competitor context only).
Volume estimates ("15-25 events/year," "50-100 events/year")	Brief individual-signal volume estimates	Plain-language estimate	Use only with explicit "estimated" language.

No bare KPI targets

No "55% open rate" / "8% reply rate" — the "What to Track" frame names metrics, not forecasts.

Vendor-reported claims qualified

Assured's "2 business days" and "99.5% accuracy" are vendor-reported. Cold copy uses industry-baseline framing or attaches a "vendor-reported" qualifier.

No specific dollar savings claims

$110K-$750K revenue/clinician and $4,200-$5,800 per-provider savings are vendor-reported and omitted from cold copy.

Competitor mentions earned, not name-dropped

Medallion / Symplr / Verifiable / CertifyOS named only in Play 5 (detractor signal), Play 2 (objection handling), and the executive context — never as casual put-downs in Plays 1, 3, 8.

Assured-specific market read

Where Assured wins, where it loses, where the gaps are.

Where Assured wins

→ Series A-C digital-health platforms scaling multi-state who need both speed AND audit-ready compliance (NCQA CVO is the differentiator)
→ Founder-led pre-Series-A digital health where the cap-table angel network (Atria, Grow Therapy founders) generates warm-intro flow
→ Buyers actively frustrated with Medallion's reported support gaps, errors, rigid workflows, and pricing tiers gating automation
→ PE-backed multi-site groups doing M&A integrations where 50-5,000-provider scaling without workflow change is a deal-thesis match
→ Behavioral-health digital platforms working through PSYPACT / Counseling Compact state activations where the payer-enrollment math lags the licensure math
→ Mid-stage orgs that have outgrown a single credentialing manager but can't justify Symplr's enterprise contract

Where Assured loses

→ Symplr-embedded enterprise IDNs where switching cost dwarfs speed gains (12-18-month sales cycles, 9-of-10 US hospitals already using Symplr)
→ Verifiable-API-first technical buyers who want raw API access and have engineering to build their own UX
→ Buyers waiting for Medallion CredAlliance payer-side traction before switching
→ Capital-asymmetry losses: $6M seed vs. Medallion's $130M means Assured can't outspend on enterprise sales firepower
→ Single-state stable orgs without expansion pressure — credentialing throughput isn't an existential question for them yet

Gaps Assured can own

→ Compact-membership additions (Play 7) — none of Medallion / Symplr / Verifiable / CertifyOS appear to monitor compact-state activations as a trigger; thin-volume, high-leverage
→ PE bolt-on + health-system M&A targeting (Plays 3, 8) — most credentialing vendors don't connect PE deal-flow to outbound; Assured's behavioral-health and PE customer base gives reference credibility
→ Vendor-complaint signal (Play 5) — Assured's competitor-comparison content library is purpose-built for this funnel; direct landing-page fit
→ OIG LEIE peer events (Play 9) — compliance-officer outreach from peer-pressure events is largely uncontested in the credentialing-vendor space
→ Customer-base aggregated benchmark productization — once Assured packages FTE-to-provider ratios, FPAR by state, and denial-rate-by-payer into a prospect-facing artifact, Plays 2 and 4 cross from Cat B to Cat A primary

+ Context — principles + market backdrop

Core Principles

Three rules behind every play.

01_

Public substrate first.

Funding announcements, exec moves, PE M&A reports, OIG exclusions, SEC filings, compact-state registries. Facts the recipient can look up. No "we work with platforms like yours."

02_

Lead with the trigger, not the pitch.

Name the round size, the state target, the bolt-on entity, the new exec's start date. Product lands after the recipient agrees the situation is real.

03_

Operator voice, not vendor voice.

"The math compounds fast," not "scalable enterprise solutions." "90-120 days per payer," not "AI-powered automation." COO, not "ops stakeholder."

Why this market, why now

Assured builds AI-native credentialing, payer enrollment, and licensing for digital-health and PE-backed multi-site groups. $6M Seed (October 2025, First Round Capital + Kindred Ventures + founders of Atria and Grow Therapy). NCQA-certified CVO (Credentials Verification Organization). 30% month-over-month growth. Customers include Blossom Health, Tono Health, Birches Health, SOL Mental Health, Platinum Dermatology, Houston Methodist.

The buyer side is squeezed from four angles at once: Joint Commission's January 2026 SAFER matrix, tighter NCQA recredentialing timeframes, payer denials climbing to 15-17% in 2026, and a digital-health Series B/C funding wave deploying capital into expansion plans that credentialing throughput cannot meet at the industry-baseline 60-120 day per-payer cycle. Medallion's $43M raise and CredAlliance launch (August 2025) put capital pressure on Assured to defend its segment niche.

Almost none of these buyers are actively shopping. The strongest signals are operational moments that force a credentialing-system review against an external clock — what this playbook detects.

What This Playbook Doesn't Solve

Where this approach falls short.

No Cat A primary plays — Assured has aggregated benchmark data across hundreds of customer orgs (FPAR by state, cred-turnaround by specialty, denial-rate by payer) but hasn't yet packaged it into a prospect-facing artifact. Once it does, Plays 2 and 4 cross to Cat A primary.
Enterprise-IDN segment underserved at the top tier — Joint Commission survey window (Play 6) ships but the 12-18-month sales cycle exceeds what $6M-seed-stage GTM firepower can carry. Houston Methodist is Assured's lone large-IDN logo; until that pattern repeats, IDN is a beachhead, not a focus motion.
Vendor-complaint signal (Play 5) requires identity enrichment that's hard at scale — Reddit usernames + Capterra anonymized reviews don't always trace to a named org. Limits play to ~50-200 high-conviction events/year vs. larger raw signal volume.
Joint Commission Quality Check has no documented public API — Play 6 detection requires a Playwright headless scrape; no clean structured endpoint. Medium-feasibility automation, not high.
Public-co credentialing receivable disclosure (Play 10) is rare — 5-15 high-conviction events per year. High-value but low-volume; doesn't carry sustained pipeline by itself.
Medallion CredAlliance unknown unknowns — if Medallion's payer-side product gains material traction with major commercial payers, the buyer's "wait and see" objection in Play 6 gets stronger. Pre-empt with a CredAlliance-positioning section by Q3 if needed.

Data Sources

The full source stack.

Mapped by play in the menu above. Most links are public and free; UserGems / Champify / PitchBook require paid subscriptions.

Source	What It Tracks	Where to Find It
Crunchbase	Series B/C funding announcements, round size, organization industry, announcement text (Plays 1, 4)	crunchbase.com
Fierce Healthcare Fundraising Tracker	Digital-health funding events with editorial commentary on expansion language (Play 1)	fiercehealthcare.com
UserGems / Champify	LinkedIn job-change tracking by title + industry filter (Play 2)	usergems.com · champify.io
LinkedIn Sales Navigator	Manual saved-search fallback for new-exec hires + cred-lead identification (Plays 2, 3, 8, 10)	linkedin.com/sales
PESP (Private Equity Stakeholder Project)	Monthly PE healthcare M&A reports — platform, acquired entity, specialty, state (Play 3)	pestakeholder.org
Behavioral Health Business	Behavioral-health-specific M&A coverage + close-date confirmation (Play 3)	bhbusiness.com
PitchBook	M&A feed (paid) — alternative for PESP for richer deal-flow data (Play 3)	pitchbook.com
TheirStack	Job postings (credentialing specialist / MSS / payer enrollment) by NAICS + headcount (Play 4)	theirstack.com
Reddit / Capterra / G2	Vendor detractor reviews + credentialing-professional discussions (Play 5)	reddit.com/r/CredentialingProfessionals · capterra.com · g2.com
Joint Commission Quality Check	Public accreditation database — facility status, last decision date (Play 6)	qualitycheck.org
Compact registries	Member-state lists for PSYPACT, Counseling Compact, IMLC, Social Work Compact (Play 7)	psypact.org · counselingcompact.org · imlcc.org
Modern Healthcare / Becker's	Health-system M&A coverage RSS (Play 8)	modernhealthcare.com · beckershospitalreview.com
OIG LEIE	Monthly exclusion CSV — exclusion type, date, specialty, state (Play 9)	oig.hhs.gov/exclusions
SEC EDGAR EFTS	Full-text search across 10-K, 10-Q, 8-K filings for credentialing-related disclosures (Plays 8, 10)	sec.gov/edgar

The Offer

This is a working sample.

The actual service is building plays like these for your TAM and running them.

Want me to build one for your company?

Get in touch →

// Changelog

2026-05-08 (Wave 2.5) — Methodology + composite scoring merged into one accordion ("+ Scoring methodology + per-play scores"). Two disclosures collapsed into one per attention-budget audit recommendation.
2026-05-08 (Wave 2) — Cut, don't add. Hero trimmed (data-stack listing + 90 words gone). Three Principles + Executive Context demoted behind one "+ Context" expandable. TOC demoted behind "+ Page contents" expandable. Portfolio Note inner content demoted behind "+ Substrate distribution" expandable. Composite tags added to deep-play headers (4.80 / 4.35 / 4.25). Selective inline jargon parens (FPAR, MSS, CVO, Medi-Cal MCO, Q+1) on first occurrence. Activation post-table paragraph tightened. Skipped from original Wave 2: per-play generic-vs-signal email pairs (The Shift already does this lesson), 48-hr benchmark fold-in (Audience-B feedback, out of scope for portfolio readers). Goal: scroll path hero → The Shift → Activation → Deep Plays under 30 seconds.
2026-05-08 (Wave 1) — Restructure for scroll momentum. Composite scores surfaced in activation table; methodology section added (5-dimension weighted rubric, full per-dimension table). Role-play personas restructured to digestible cards (killer-catch + edits-driven visible; transcripts collapsed). Plays 4–10 demoted to "+ See 7 more plays" expandable, ranked by composite. Claim sources demoted to expandable. Source: feedback-log.md C1 (graduated to _CONVENTIONS.md) + Lucas redesign brief.
2026-05-08 — Initial publish. Ten plays, three deep dives (Series B/C state-expansion, new-COO 90-day stack-review, PE bolt-on integration), full role-play transcripts (Sarah / Marcus / Janet), revision log, claim sources, and the complete data-source stack.

An Operational Trigger Intelligence playbook built for Assured.

Every credentialing rep sounds the same. Assured doesn't have to.

Run these three first.

Three plays with full architecture.

Series B/C with state-expansion math gap

New COO 90-day stack-review window

PE bolt-on integration math

Three subagents read the cold emails in character. This is what they said.

Sarah Chen — digital-health COO, Series B closed 7 weeks ago

Scene

Pre-revision Variant A

Pre-revision Variant B

Sarah's reaction · 7:50am, between standup and the 9am with Karen

Marcus Patel — new COO at Series A virtual-care, 52 days in role

Scene

Pre-revision Variant A

Pre-revision Variant B

Marcus's reaction · 4:15pm, between the 4 and the 5

Janet Rodríguez — CFO at PE-backed dermatology platform, 39 days post-bolt-on

Scene

Pre-revision Variant A

Pre-revision Variant B

Janet's reaction · 3:30pm, Audax deck still open on the main monitor

What got cut, and the catch that drove it.

Three pain-point clusters.

Composite scoring rubric.

Seven more plays. Ranked by composite.

Health-system / multi-site M&A integration

Behavioral-health licensure-compact false-comfort wedge

Medallion / Symplr / Verifiable detractor signal

Joint Commission survey window 12–18 months out

Credentialing-team hiring vs. provider-count ratio

OIG LEIE peer-segment exclusion event

Public-co credentialing receivable disclosure

Every number, sourced.

Where Assured wins, where it loses, where the gaps are.

Three rules behind every play.

Where this approach falls short.

The full source stack.

This is a working sample.

An Operational Trigger Intelligence playbook
built for Assured.